Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Butofilolol, (+-)-isomer
2. Cafide
3. Cm 6805
4. Cm-6805
1. Cafide
2. 58930-32-8
3. 64552-17-6
4. 1-[2-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-5-fluorophenyl]-1-butanone
5. Butofilolol [inn]
6. Cm-6805
7. 4azc6y5a8g
8. 1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl]butan-1-one
9. 1-(2-(3-(tert-butylamino)-2-hydroxypropoxy)-5-fluorophenyl)butan-1-one
10. (+/-)-2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorobutyrophenone
11. 2'-(3-(tert-butylamino)-2-hydroxypropoxy)-5'-fluorobutyrophenone
12. 1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl}butan-1-one
13. 1-butanone, 1-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-5-fluorophenyl)-
14. Unii-4azc6y5a8g
15. Butofilololum [inn-latin]
16. Einecs 261-502-5
17. Cm 6805
18. Butofilolol [mi]
19. Butofilolol [mart.]
20. Schembl78268
21. Chembl157443
22. Dtxsid30867082
23. Chebi:135327
24. Bbl101859
25. Mfcd00864575
26. Stl555656
27. Akos007930875
28. Hy-w096097
29. As-73617
30. Cs-0147735
31. L013404
32. Sr-01000945082
33. Q5002736
34. Sr-01000945082-1
35. 1-{2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl}-1-butanone
| Molecular Weight | 311.4 g/mol |
|---|---|
| Molecular Formula | C17H26FNO3 |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 9 |
| Exact Mass | 311.18967185 g/mol |
| Monoisotopic Mass | 311.18967185 g/mol |
| Topological Polar Surface Area | 58.6 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 343 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Adrenergic beta-Antagonists
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)
ABOUT THIS PAGE
70
PharmaCompass offers a list of Butofilolol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Butofilolol manufacturer or Butofilolol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Butofilolol manufacturer or Butofilolol supplier.
PharmaCompass also assists you with knowing the Butofilolol API Price utilized in the formulation of products. Butofilolol API Price is not always fixed or binding as the Butofilolol Price is obtained through a variety of data sources. The Butofilolol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Butofilolol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Butofilolol, including repackagers and relabelers. The FDA regulates Butofilolol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Butofilolol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Butofilolol supplier is an individual or a company that provides Butofilolol active pharmaceutical ingredient (API) or Butofilolol finished formulations upon request. The Butofilolol suppliers may include Butofilolol API manufacturers, exporters, distributors and traders.
Butofilolol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Butofilolol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Butofilolol GMP manufacturer or Butofilolol GMP API supplier for your needs.
A Butofilolol CoA (Certificate of Analysis) is a formal document that attests to Butofilolol's compliance with Butofilolol specifications and serves as a tool for batch-level quality control.
Butofilolol CoA mostly includes findings from lab analyses of a specific batch. For each Butofilolol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Butofilolol may be tested according to a variety of international standards, such as European Pharmacopoeia (Butofilolol EP), Butofilolol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Butofilolol USP).
